Minicapsules encapsulating nanoparticles for targeting, apoptosis induction and treatment of colon cancer

References

• Prabhudesai SG, Rekhraj S, Roberts G, et al. Apoptosis and chemo-resistance in colorectal cancer. J Surg Oncol. 2007;96:77–88.
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–1659.
   PubMed Web of Science ®Google Scholar
• Fadeel B, Xue D, Kagan V. Programmed cell clearance: molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation. Biochem Biophys Res Commun. 2010;396:7–10.
   PubMed Web of Science ®Google Scholar
• Wong RSY. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87.
   PubMed Web of Science ®Google Scholar
• Vermeulen K, Van Bockstaele DR, Berneman ZN. Apoptosis: mechanisms and relevance in cancer. Ann Hematol. 2005;84:627–639.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Khatik R, Dwivedi P, Junnuthula VR, et al. Potential in vitro and in vivo colon specific anticancer activity in a HCT-116 xenograft nude mice model: targeted delivery using enteric coated folate modified nanoparticles. RSC Adv. 2015;5:16507–16520.
   Web of Science ®Google Scholar
• Khatik R, Mishra R, Verma A, et al. Colon-specific delivery of curcumin by exploiting Eudragit-decorated chitosan nanoparticles in vitro and in vivo. J Nanoparticle Res. 2013;15:1893.
   Web of Science ®Google Scholar
• Saphier S, Rosner A, Brandeis R, et al. Gastro-intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imaging. Int J Pharma. 2010;388:190–195.
   PubMed Web of Science ®Google Scholar
• Jain A, Jain S, Jain R, et al. Coated chitosan nanoparticles encapsulating caspase 3 activator for effective treatment of colorectral cancer. Drug Deliv Transl Res. 2015;5:596–610.
   PubMed Web of Science ®Google Scholar
• Sarkar J, Singh N, Meena S, et al. Staurosporine induces apoptosis in human papillomavirus positive oral cancer cells at G2/M phase by disrupting mitochondrial membrane potential and modulation of cell cytoskeleton. Oral Oncol. 2009;45:974–979.
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release. 2004;100:5–28.
   PubMed Web of Science ®Google Scholar
• Khatik R, Dwivedi P, Shukla A, et al. Development, characterization and toxicological evaluations of phospholipids complexes of curcumin for effective drug delivery in cancer chemotherapy. Drug Deliv. 2016;23:1067–1078.
   PubMed Web of Science ®Google Scholar
• Vredenburg MR, Ojima I, Veith J, et al. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. J Natl Cancer Inst. 2001;93:1234–1245.
   PubMedGoogle Scholar
• Kurata N, Kuramitsu T, Tanii H, et al. Development of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urine. J Chromatogr B. 1998;708:223–227.
   PubMed Web of Science ®Google Scholar
• Jain A, Mehra NK, Nahar M, et al. Topical delivery of enoxaparin using nanostructured lipid carrier. J Microencapsul. 2013;30:709–715.
   PubMed Web of Science ®Google Scholar
• Xu Z, Gu W, Huang J, et al. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm. 2005;288:361–368.
   PubMed Web of Science ®Google Scholar
• Trickler WJ, Nagvekar AA, Dash AK. A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS PharmSciTech. 2008;9:486–493.
   PubMed Web of Science ®Google Scholar
• Wang X, Chi N, Tang X. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharma Biopharma. 2008;70:735–740.
   PubMed Web of Science ®Google Scholar
• Jain A, Jain SK, Ganesh N, et al. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine. 2010;6:179–190.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Lin FH, Tsai KC, et al. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjugate Chem. 2010;21:679–689.
   PubMed Web of Science ®Google Scholar
• Sahu SK, Mallick SK, Santra S, et al. In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci: Mater Med. 2010;21:1587–1597.
   PubMed Web of Science ®Google Scholar
• Ramasamy S, Abdul Wahab N, Zainal Abidin N, et al. Growth inhibition of human gynecologic and colon cancer cells by Phyllanthus watsonii through apoptosis induction. PLoS One. 2012;7:e34793.
   PubMed Web of Science ®Google Scholar
• Akinaga S, Nomura K, Gomi K, et al. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells. Cancer Chemother Pharmacol. 1994;33:273–280.
   PubMed Web of Science ®Google Scholar
• Chen X, Lowe M, Keyomarsi K. UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent. Oncogene. 1999;18:5691–5702.
   Web of Science ®Google Scholar
• Abe S, Kubota T, Otani Y, et al. UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery. Jpn J Cancer Res. 2001;92:537–545.
   PubMedGoogle Scholar
• Wang W, Bu B, Xie M, et al. Neural cell cycle dysregulation and central nervous system diseases. Progr Neurobiol. 2009;89:1–17.
   PubMed Web of Science ®Google Scholar
• Pages F, Galon J, Dieu-Nosjean MC, et al. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010;29:1093–1102.
   PubMed Web of Science ®Google Scholar
• Kantola T, Klintrup K, Vayrynen JP, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma'. Br J Cancer. 2013;108:1917–1918.
   PubMed Web of Science ®Google Scholar
• Naugler WE, and Karin M. The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends in Molecular Medicine. 2008;14:109–119.
   PubMed Web of Science ®Google Scholar
• Knupfer H, and Preiss R. Serum interleukin-6 levels in colorectal cancer patients -a summary of published results. International Journal of Colorectal Disease. 2010;25:135–140.
   PubMed Web of Science ®Google Scholar